Latest News

IperionX blasts short seller report as shares plunge 24% after halt

IperionX Ltd, an Australian titanium manufacturer, "strongly" rejected a critical report from Spruce Capital on Monday. Its shares fell as much as 24,4% after the trading halt lifted.

IperionX shares dropped to A$4.24 at the opening of early trading, the lowest price since July 10. This was the largest decline on the benchmark S&P/ASX 200 Index, which fell 0.2%.

IperionX stopped trading on Thursday last week to prepare a reply to Spruce Point’s 93-page study, in which the company was accused of exaggerating its prospects, denying its valuation, and questioning project claims.

The short seller raised concerns about discrepancies with project data and finances, despite announcing a A$17,000,000 ($11.11,000,000) supply agreement with Ford Motor Co. The short seller also cast doubts on the management's credibility by citing links with Piedmont Lithium which was previously targeted.

IperionX, in its rebuttal to the criticism, said that it stood by its technology. It cited government funding of about $47,000,000 to scale up titanium production.

Taso Arima, the chief executive of Taso Arima Corporation, said that a recent Pentagon deal "underscores U.S. Government's commitment to reshore a all-American supply chain for titanium" and confirmed plans to increase production at its Virginia facility.

IperionX stated that Spruce Point never contacted its management prior to publishing the report, and has never visited its titanium operations in Virginia.

Spruce Point’s attack has put the company's shares to the test. They have tripled in value since 2024.

In 2022, the lithium developer Lake Resources fell after a short seller report. Piedmont Lithium - once headed by IperionX CEO - faced similar allegations in 2017.

(source: Reuters)